Richard L. Casey
Keine laufenden Positionen mehr
Profil
Richard L.
Casey served as Chairman & CEO at Scios, Inc. and Cellgate, Inc. He was also President & CEO at Neuraltus Pharmaceuticals, Inc. for a year.
Prior to that, he was Executive VP at ALZA Corp.
and Vice President-Sales at Syntex Laboratories, Inc. He started his career as a Principal at Eli Lilly & Co. Mr. Casey holds an undergraduate degree and an MBA from Stanford University.
Ehemalige bekannte Positionen von Richard L. Casey
| Unternehmen | Position | Ende |
|---|---|---|
Cellgate, Inc.
 Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA. | Vorsitzender | 22.06.2009 |
| ALZA CORPORATION | Corporate Officer/Principal | - |
| Syntex Laboratories, Inc. | Vertrieb & Marketing | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Vorstandsvorsitzender | - |
Ausbildung von Richard L. Casey
| Stanford University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Cellgate, Inc.
Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA. | Health Technology |
Neuraltus Pharmaceuticals, Inc.
 Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA. | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
| Syntex Laboratories, Inc. | |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
